-
Something wrong with this record ?
Non-invasive prenatal testing (NIPT): Combination of copy number variant and gene analyses using an "in-house" target enrichment next generation sequencing-Solution for non-centralized NIPT laboratory
L. Faldynová, S. Walczysková, D. Černá, M. Kudrejová, Š. Hilscherová, R. Kaniová, S. Širůčková
Language English Country England, Great Britain
Document type Journal Article
Grant support
(FNOs/2019).
Ministry of Health, Czech Republic
PubMed
37602788
DOI
10.1002/pd.6421
Knihovny.cz E-resources
- MeSH
- Laboratories * MeSH
- Humans MeSH
- Chromosomes, Human, Pair 21 MeSH
- Pregnancy MeSH
- DNA Copy Number Variations MeSH
- Cell-Free Nucleic Acids * MeSH
- High-Throughput Nucleotide Sequencing MeSH
- Check Tag
- Humans MeSH
- Pregnancy MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
OBJECTIVE: Recent studies have integrated copy number variant (CNV) and gene analysis using target enrichment. Here, we transferred this concept to our routine genetics laboratory, which is not linked to centralized non-invasive prenatal testing (NIPT) facilities. METHOD: From a cohort of 100 pregnant women, 22 were selected for the analysis of maternal genomic DNA (gDNA) along with fetal cell-free DNA. Using targeted enrichment, 135 genes were analyzed, combined with aberrations of chromosomes 21, 18, 13, X, and Y. The data were subjected to specificity and sensitivity analyses, and correlated with the results from invasive testing methods. RESULTS: The sensitivity/specificity was determined for the CNV analysis of chromosomes: 21 (80%/75%), 18 (-/82%), 13 (100%/67%), and Y (100%/100%). The gene detection was valid for maternal gDNA. However, for cell-free fetal DNA, it was not possible to determine the boundary between an artifact and a real sequence variant. CONCLUSION: The target enrichment method combining CNV and gene detection seems feasible in a regular laboratory. However, this method can only be responsibly optimized with a sufficient number of controls and further validation on a strong bioinformatic background. The present results showed that NIPT should be performed in specialized centers, and that its introduction to isolated laboratories may not provide valid data.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23016314
- 003
- CZ-PrNML
- 005
- 20240312074521.0
- 007
- ta
- 008
- 231013s2023 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/pd.6421 $2 doi
- 035 __
- $a (PubMed)37602788
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Faldynová, Lucie $u Department of Molecular and Clinical Pathology and Medical Genetics, University Hospital Ostrava, Ostrava, Czech Republic $1 https://orcid.org/0009000717975874 $7 xx0314699
- 245 10
- $a Non-invasive prenatal testing (NIPT): Combination of copy number variant and gene analyses using an "in-house" target enrichment next generation sequencing-Solution for non-centralized NIPT laboratory / $c L. Faldynová, S. Walczysková, D. Černá, M. Kudrejová, Š. Hilscherová, R. Kaniová, S. Širůčková
- 520 9_
- $a OBJECTIVE: Recent studies have integrated copy number variant (CNV) and gene analysis using target enrichment. Here, we transferred this concept to our routine genetics laboratory, which is not linked to centralized non-invasive prenatal testing (NIPT) facilities. METHOD: From a cohort of 100 pregnant women, 22 were selected for the analysis of maternal genomic DNA (gDNA) along with fetal cell-free DNA. Using targeted enrichment, 135 genes were analyzed, combined with aberrations of chromosomes 21, 18, 13, X, and Y. The data were subjected to specificity and sensitivity analyses, and correlated with the results from invasive testing methods. RESULTS: The sensitivity/specificity was determined for the CNV analysis of chromosomes: 21 (80%/75%), 18 (-/82%), 13 (100%/67%), and Y (100%/100%). The gene detection was valid for maternal gDNA. However, for cell-free fetal DNA, it was not possible to determine the boundary between an artifact and a real sequence variant. CONCLUSION: The target enrichment method combining CNV and gene detection seems feasible in a regular laboratory. However, this method can only be responsibly optimized with a sufficient number of controls and further validation on a strong bioinformatic background. The present results showed that NIPT should be performed in specialized centers, and that its introduction to isolated laboratories may not provide valid data.
- 650 _2
- $a těhotenství $7 D011247
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a laboratoře $7 D007753
- 650 _2
- $a vysoce účinné nukleotidové sekvenování $7 D059014
- 650 _2
- $a variabilita počtu kopií segmentů DNA $7 D056915
- 650 12
- $a volné cirkulující nukleové kyseliny $7 D000073888
- 650 _2
- $a lidské chromozomy, pár 21 $7 D002891
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Walczysková, Sylwia $u Department of Molecular and Clinical Pathology and Medical Genetics, University Hospital Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Černá, Dita $u Department of Molecular and Clinical Pathology and Medical Genetics, University Hospital Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Kudrejová, Monika $u Department of Molecular and Clinical Pathology and Medical Genetics, University Hospital Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Hilscherová, Šárka $u Department of Molecular and Clinical Pathology and Medical Genetics, University Hospital Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Kaniová, Romana $u Department of Molecular and Clinical Pathology and Medical Genetics, University Hospital Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Širůčková, Simona $u Department of Molecular and Clinical Pathology and Medical Genetics, University Hospital Ostrava, Ostrava, Czech Republic
- 773 0_
- $w MED00003882 $t Prenatal diagnosis $x 1097-0223 $g Roč. 43, č. 10 (2023), s. 1320-1332
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37602788 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20231013 $b ABA008
- 991 __
- $a 20240312074518 $b ABA008
- 999 __
- $a ok $b bmc $g 2000059 $s 1202676
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 43 $c 10 $d 1320-1332 $e 20230821 $i 1097-0223 $m Prenatal diagnosis $n Prenat Diagn $x MED00003882
- GRA __
- $a (FNOs/2019). $p Ministry of Health, Czech Republic
- LZP __
- $a Pubmed-20231013